Table 3.
Baseline features and outcome parameters in patients with chronic Achilles tendinopathy after PSM.
| Characteristics | ST group (n = 17) | LT group (n = 17) | t (χ2) | p |
|---|---|---|---|---|
| Gender [n (%)] | ||||
| Male | 6 (35.3) | 4 (23.5) | 0.567 | 0.452 |
| Female | 11 (64.7) | 13 (76.5) | ||
| Sports [n (%)] | ||||
| Yes | 12 (70.6) | 8 (47.1) | 1.943 | 0.163 |
| No | 5 (29.4) | 9 (52.9) | ||
| Sides [n (%)] | ||||
| Superiority | 10 (58.8) | 10 (58.8) | 0 | 1 |
| Nonsuperiority | 7 (41.2) | 7 (41.2) | ||
| Type [n (%)] | ||||
| Insertion | 6 (35.3) | 7 (41.2) | 0.124542 | 0.724 |
| Noninsertion | 11 (64.7) | 10 (58.8) | ||
| BMI | 23.96 ± 1.93 | 24.11 ± 2.25 | 0.215 | 0.831 |
| Age (y) | 59.91 ± 9.62 | 61.34 ± 9.33 | 0.441 | 0.662 |
| Preintervention | ||||
| AOFAS | 65.43 ± 10.05 | 62.80 ± 11.90 | 0.695 | 0.492 |
| VAS | 5.92 ± 1.12 | 5.87 ± 1.10 | 0.127 | 0.9 |
| Postintervention | ||||
| AOFAS | 85.08 ± 9.83∆∆ | 76.76 ± 9.85∆∆ | 2.464 | 0.019∗∆ |
| VAS | 1.96 ± 0.98∆∆ | 2.24 ± 1.29∆∆ | 0.703 | 0.487 |
| Sat. rate [n (%)] | 12 (70.6) | 8(47.1) | 1.943 | 0.163 |
∗Compared with ST group in same period, the difference is significant, and p < 0.05; ∆∆compared with preintervention in same group, the difference is significant, and p < 0.01.